Cencora Inc. $(COR)$ has priced a series of senior notes in an underwritten registered public offering. The company announced the issuance of $500 million of 3.950% Senior Notes due 2029, $500 million of 4.250% Senior Notes due 2030, $500 million of 4.600% Senior Notes due 2033, $1.0 billion of 4.900% Senior Notes due 2036, and $500 million of 5.650% Senior Notes due 2056. The proceeds will be used to repay amounts outstanding under Cencora's 364-Day Term Credit Agreement, which was used to fund part of its acquisition of OneOncology, and for general corporate purposes. The offering is expected to close on February 13, 2026, subject to customary closing conditions. Electronic copies of the preliminary prospectus supplement and accompanying prospectus are available on the SEC's web site at www.sec.gov.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260210480644) on February 10, 2026, and is solely responsible for the information contained therein.